Cargando…
Discovery of novel peptides targeting pro-atherogenic endothelium in disturbed flow regions -Targeted siRNA delivery to pro-atherogenic endothelium in vivo
Atherosclerosis occurs preferentially in arterial regions exposed to disturbed blood flow. Targeting these pro-atherogenic regions is a potential anti-atherogenic therapeutic approach, but it has been extremely challenging. Here, using in vivo phage display approach and the partial carotid ligation...
Autores principales: | Chung, Jihwa, Shim, Hyunbo, Kim, Kwanchang, Lee, Duhwan, Kim, Won Jong, Kang, Dong Hoon, Kang, Sang Won, Jo, Hanjoong, Kwon, Kihwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901192/ https://www.ncbi.nlm.nih.gov/pubmed/27173134 http://dx.doi.org/10.1038/srep25636 |
Ejemplares similares
-
Arsenic Exposure Increases Monocyte Adhesion to the Vascular Endothelium, a Pro-Atherogenic Mechanism
por: Lemaire, Maryse, et al.
Publicado: (2015) -
Ursodeoxycholic Acid (UDCA) Exerts Anti-Atherogenic Effects by Inhibiting RAGE Signaling in Diabetic Atherosclerosis
por: Chung, Jihwa, et al.
Publicado: (2016) -
Ursodeoxycholic Acid (UDCA) Exerts Anti-Atherogenic Effects by Inhibiting Endoplasmic Reticulum (ER) Stress Induced by Disturbed Flow
por: Chung, Jihwa, et al.
Publicado: (2015) -
The Endothelium as a Target for Anti-Atherogenic Therapy: A Focus on the Epigenetic Enzymes EZH2 and SIRT1
por: Fledderus, Jolien, et al.
Publicado: (2021) -
Atherogenic, fibrotic and glucose utilising actions of glucokinase activators on vascular endothelium and smooth muscle
por: Al-aryahi, Sefaa, et al.
Publicado: (2014)